Education Tools to Support Pediatric Survivor Care

NCT04257058 | Completed Results

• 2 other identifiers: IRB00091839R01CA218389
• Study Type: interventional
• Target: 89
• Locations: 1 country
• Sites: 1

Brief Summary

This study aims to evaluate the impact of electronic educational materials on adolescent and young adult (AYA) survivors' knowledge about late effects, perceived benefits, self-efficacy, and intentions to engage in lifelong survivor care.

Conditions

Cancer; Pediatric Cancer

Keywords

Behavioral study; Social study; Pediatric cancer

Outcome Measures

Primary Outcomes (1)

• Survivor Care Knowledge Scale

  Knowledge was assessed at baseline and 2 weeks post-intervention, with the Survivor Care Knowledge scale, that includes 15-item multiple-choice quiz to assess participants' knowledge of the content covered in the electronic educational materials previously provided. Total score ranges from 0-15. Higher score is associated with better outcome.

  Baseline, 2 weeks post-intervention

Secondary Outcomes (5)

• Benefits for Survivor Care

  Baseline, 2 weeks post-intervention

• Barriers for Survivor Care

  Baseline, 2 weeks post-intervention

• Perceived Susceptibility for Late Effects

  Baseline, 2 weeks post-intervention

• Intentions for Survivor Care

  Baseline, 2 weeks post-intervention

• Change in Perceived Health Competence Scale (PHCS)

  Baseline, 2 weeks post-intervention

Study Arms (1)

Electronic educational material

EXPERIMENTAL

Participants in the trial included young adult survivors of childhood cancer. Participants completed an online pre-test survey via REDCap. After the pre-test is completed, participants review electronic media in REDCap. Study staff confirmed review of material and scheduled a post-test survey to be competed in REDCap two weeks after material is reviewed.

Behavioral: Electronic educational material

Interventions

Electronic educational material BEHAVIORAL

Electronic media via email

Electronic educational material

Eligibility Criteria

• Age: 18 Years - 25 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• Patients must be 18-25 years of age,
• Diagnosed with cancer at ≤ 18 years of age,
• ≥ 2 years since the last cancer treatment,
• seen at least once in the Aflac Cancer Survivor Program (CSP) in the past 2 years or transitioned out of the Aflac CSP to adult survivor care since 2013.

You may not qualify if:

• Patients will be excluded from participation in the study if the participant is non-English speaking.
• Young adult survivors who are cognitively impaired and unable to complete the questionnaires.
• Participants that do not consent to the recording of their interviews.

Sponsors & Collaborators

• Emory University: lead
• National Cancer Institute (NCI): collaborator

Study Sites (1)

Children's Healthcare of Atlanta

Atlanta, Georgia, 30322, United States

Location

MeSH Terms

Conditions

Neoplasms

Results Point of Contact

• Title: Dr. Jordan Marchak
• Organization: Emory University

jgillel@emory.edu

404-727-2293

Study Officials

• Jordan Marchak, PhD

  Emory University

  PRINCIPAL INVESTIGATOR

Publication Agreements

• PI is Sponsor Employee: Yes

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Professor

Study Record Dates

• First Submitted: February 4, 2020
• First Posted: February 5, 2020
• Study Start: June 7, 2022
• Primary Completion: April 13, 2024
• Study Completion: April 13, 2024
• Last Updated: May 15, 2025
• Results First Posted: May 15, 2025

Record last verified: 2025-05

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)